Your browser doesn't support javascript.
loading
Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia.
Kwak, Jae-Yong; Kim, Sung-Hyun; Oh, Suk Joong; Zang, Dae Young; Kim, Hawk; Kim, Jeong-A; Do, Young Rok; Kim, Hyeoung Joon; Park, Joon Seong; Choi, Chul Won; Lee, Won Sik; Mun, Yeung-Chul; Kong, Jee Hyun; Chung, Joo Seop; Shin, Ho-Jin; Kim, Dae-Young; Park, Jinny; Jung, Chul Won; Bunworasate, Udomsak; Comia, Narcisa Sonia; Jootar, Saengsuree; Reksodiputro, Arry Harryanto; Caguioa, Priscilla B; Lee, Sung-Eun; Kim, Dong-Wook.
Afiliación
  • Kwak JY; Chonbuk National University Medical School & Hospital, Jeonju, South Korea.
  • Kim SH; Dong-A University Medical Center, Busan, South Korea.
  • Oh SJ; Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Zang DY; Hallym University Sacred Heart Hospital, Anyang, South Korea.
  • Kim H; Ulsan University Hospital, Ulsan, South Korea.
  • Kim JA; St. Vincent Hospital, The Catholic University of Korea, Suwon, South Korea.
  • Do YR; Dongsan Medical Center, Keimyung University, Daegu, South Korea.
  • Kim HJ; Chonnam National University, Hwasun Hospital, Hwasun, South Korea.
  • Park JS; Ajou University Hospital, Suwon, South Korea.
  • Choi CW; Korea University, Guro Hospital, Seoul, South Korea.
  • Lee WS; Inje University Busan Paik Hospital, Busan, South Korea.
  • Mun YC; Ewha Womans University Mokdong Hospital, Seoul, South Korea.
  • Kong JH; Wonju Severance Christian Hospital, Wonju, South Korea.
  • Chung JS; Pusan National University Hospital, Busan, South Korea.
  • Shin HJ; Pusan National University Hospital, Busan, South Korea.
  • Kim DY; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Park J; Gachon University Gil Medical Center, Seoul, South Korea.
  • Jung CW; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Bunworasate U; King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
  • Comia NS; Mary Mediatrix Medical Center, Lipa, Philippine.
  • Jootar S; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Reksodiputro AH; Rumah Sakit Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
  • Caguioa PB; St. Luke's Medical Center, Manila, Philippines.
  • Lee SE; Seoul St. Mary's Hospital, Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea.
  • Kim DW; Seoul St. Mary's Hospital, Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea. dwkim@catholic.ac.kr.
Clin Cancer Res ; 23(23): 7180-7188, 2017 Dec 01.
Article en En | MEDLINE | ID: mdl-28939746
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazinas / Benzamidas / Leucemia Mieloide de Fase Crónica / Mesilato de Imatinib Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazinas / Benzamidas / Leucemia Mieloide de Fase Crónica / Mesilato de Imatinib Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos